Core Insights - Medtronic has successfully performed the first U.S. commercial surgical case using its FDA-cleared Hugo™ robotic-assisted surgery (RAS) system at Cleveland Clinic, marking a significant milestone in expanding access to minimally invasive surgery [1] Company Developments - The first procedure was a robotic-assisted prostatectomy conducted by Dr. Jihad Kaouk, who emphasized the technology's ability to customize surgical approaches for individual patients [1] - The Hugo RAS system received FDA clearance for urologic surgical procedures in December 2025, and its introduction is part of Medtronic's broader surgical offerings [1] Industry Trends - Urology has seen a high adoption rate of robotic technology, with approximately 80% of urologic abdominal surgeries in the U.S. currently performed with robotic assistance, indicating a strong trend towards robotic-assisted procedures across various specialties [1] - The Hugo RAS system's modular design aims to address operating room scheduling challenges and infrastructure limitations, potentially increasing patient access to the benefits of minimally invasive care [1] Clinical Research - Cleveland Clinic participated in the Expand URO Investigational Device Exemption (IDE) clinical study, which demonstrated that the Hugo RAS system met primary safety and effectiveness endpoints in urologic surgeries [1] - The system is expected to expand its indications into gynecologic and general surgery procedures, including hernia repair, further broadening its application in the surgical field [1]

Core Insights - Medtronic has received FDA clearance for the Stealth AXiS™ surgical system, which integrates planning, navigation, and robotics for spine surgery, marking a significant advancement in surgical technology [1] Company Overview - Medtronic is a global leader in healthcare technology, headquartered in Galway, Ireland, with over 95,000 employees across more than 150 countries [1] - The company aims to alleviate pain, restore health, and extend life through innovative technologies that address various health conditions [1] Product Details - The Stealth AXiS™ system is designed for spine procedures and has an architecture that supports future cranial and ENT applications, pending further FDA clearance [1] - This system combines familiar navigation workflows with a modular robotic design, allowing for flexibility in deployment according to clinical needs [1] Technological Innovations - A key feature of the Stealth AXiS™ system is LiveAlign™ segmental tracking, which provides real-time visualization of anatomic motion and surgical adjustments, reducing the need for repeated imaging [1] - The system is part of Medtronic's AiBLE™ smart ecosystem, facilitating a seamless flow of information across the surgical continuum [1] Market Position - Medtronic's Cranial and Spinal Technologies division serves over 4 million patients annually with a portfolio of 150 products addressing more than 20 pathologies [1] - The company focuses on building durable platforms that simplify surgical workflows while enabling future expansions across various procedures and specialties [1]